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Abstract
Background: Decision-making in child and youth mental health (CYMH) care requires recommendations that are
developed through an efficient and effective method and are based on credible knowledge. Credible knowledge is
informed by two sources: scientific evidence, and practice-based evidence, that reflects the “real world” experience
of service providers. Current approaches to developing these recommendations in relation to CYMH will typically
include evidence from one source or the other but do not have an objective method to combine the two. To this
end, a modified version of the Grading Recommendations Assessment, Development and Evaluation (GRADE)
approach was pilot-tested, a novel method for the CYMH field.
Methods: GRADE has an explicit methodology that relies on input from scientific evidence as well as a panel of experts.
The panel established the quality of evidence and derived detailed recommendations regarding the organization and
delivery of mental health care for children and youth or their caregivers. In this study a modified GRADE method was
used to provide precise recommendations based on a specific CYMH question (i.e. What is the current credible
knowledge concerning the effects of parent-implemented, early intervention with their autistic children?).
Results: Overall, it appeared that early, parent-implemented interventions for autism result in positive effects that
outweigh any undesirable effects. However, as opposed to overall recommendations, the heterogeneity of the
evidence required that recommendations be specific to particular interventions, based on the questions of whether
the benefits of a particular intervention outweighs its harms.
Conclusions: This pilot project provided evidence that a modified GRADE method may be an effective and
practical approach to making recommendations in CYMH, based on credible knowledge. Key strengths of the
process included separating the assessments of the quality of the evidence and the strength of recommendations,
transparency in decision-making, and the objectivity of the methods. Most importantly, this method combined the
evidence and clinical experience in a more timely, explicit and simple process as compared to previous
approaches. The strengths, limitations and modifications of the approach as they pertain to CYMH, are discussed.
Background
An essential ingredient in effective clinical practice is that
clinicians benefit, in a timely way, from current research
knowledge in their fields. Those responsible for the orga-
nization and delivery of child and youth mental health
(CYMH) care require such knowledge, which is rapidly
changing and ever increasing. Moreover, clinicians
benefit from knowledge that is credible. This is especially
critical in the development of clinical recommendations,
which are intended to achieve the linked objectives of
improvements in patient or client outcome and the effi-
cient use of resources. To be credible, these recommen-
dations must consider input from two sources: scientific
evidence and the practice-based evidence, reflecting
the “real world” expertise and experience of service
providers.
Clearly, it is less than practical to expect that individual
clinicians can continuously survey and evaluate available
knowledge and adapt clinical decisions accordingly.
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that need to be overcome in improving the access to and
practical application of credible knowledge in CYMH.
Primarily, there is a lack of agreement about the best
methods for organizations to identify, assess, and synthe-
size relevant studies [1-7]. Without a useful methodology
for identification and evaluation, published research
results may not be adequately assessed for their scientific
validity. Poor research, which can suffer from serious
methodological flaws, may then be relied upon to make
critical treatment decisions. On the other hand, when
recommendations are based on rigorous evaluation of
only high quality evidence, this evidence may not be
assessed for its relevance and practical application to spe-
cific care and may not be suitable for generalization to
clinicians’ practice. These flaws are present in the current
approaches to synthesizing evidence-based practice in
CYMH.
Numerous professional bodies and scientific organiza-
tions have taken the approach of developing clinical
practice guidelines. These guidelines include recommen-
dations to aid patient and practitioner decision-making
in specific clinical situations. A strength of this approach
is that a panel of experts typically develops these recom-
mendations. Panel members have access to the evidence,
an understanding of the clinical problems and research
methods, and sufficient time for deliberation. However,
the recommendations are often formulated without sys-
tematically identifying and summarizing the evidence
[8]. A proper evaluation of the evidence is critical in
ensuring the validity of guidelines. Otherwise, relevant
studies may be missed and recommendations made
which contradict the current best available evidence.
Furthermore, when more rigorous and transparent
methods are used, guideline development can take two
years or more. As a result, these guidelines can require
considerable financial and human resources and the
timeline may result in a delay in getting pertinent infor-
mation to health care providers, thereby having a poten-
tial impact on clinical practice [4,9,10].
Systematic reviews take a different approach by using
explicit search strategies and inclusion criteria to identify
and judge evidence of the effectiveness of clinical inter-
ventions [11]. The relative comprehensiveness of these
reviews is a key strength. Null or even negative findings
are often included, whereas in other approaches such
research has been largely ignored in the accumulation of
supportive findings [12]. However, health professionals,
physicians, and policy makers infrequently refer to these
reviews in decision-making [13-15]. So, despite the
increasing summaries of the evidence in systematic
reviews and clinical practice guidelines, as many as 30 to
45 per cent of patients fail to receive evidence-based
treatment, leading to less than optimal outcomes [16-18].
This is due to a number of limitations in these reviews
[11]; perhaps the most significant one being the lack of a
well-defined, transparent process for including the input
of relevant evidence users that have practice-based
knowledge. This limitation results in the omission of
i n p u tf r o mt h o s ei n t e n d e dt oi m p l e m e n ta n db e n e f i t
from the recommendations.
Input from practicing health professionals can make
recommendations more practical and clinically- relevant.
This can be accomplished through an approach that
integrates scientific evidence with the knowledge of
patients’ values and preferences as well as the implica-
tions for treatment planning and decision-making in
clinical practice.
A New Approach
The Grading of Recommendations, Assessment, Devel-
opment, and Evaluation (GRADE) approach [19] incor-
porates the strengths of previous approaches and
accounts for their limitations. It may be the more effec-
tive method for providing credible knowledge that is
essential to CYMH.
GRADE employs a sequential assessment of 1) the
quality of the evidence, followed by 2) an evaluation of
the balance between benefits and harms and 3) a subse-
quent judgment about the strength of recommendations
[20]. The separation of judgments on the quality of evi-
dence and the strength of recommendations is a critical
and defining feature of this method.
GRADE was developed based on a systematic review
that identified the fundamental elements of an effective
evidence grading system. These elements include: the
rating of the quality of individual studies; the quantity in
terms of magnitude of effect, number of studies and
sample size; and the consistency of the findings between
similar and different study designs [21].
The current approaches to synthesizing evidence-based
practice research in the CYMH field should be more
appropriately described as clinical treatment efficacy
research [22]. In the past, these approaches have relied on
a one-to-one fit between the research on effective practices
and the implementation of these practices in routine care.
One clear solution to this problem would see research
conducted that attends to service delivery issues at the
outset. However, until that sort of evidence becomes avail-
able existing evidence-based practice research would be
left collecting dust on academic shelves. Instead, the
GRADE method may provide a method that can make use
of the wealth of existing research. The GRADE approach
attempts to merge research-based knowledge of efficacy
with practice-based knowledge of effectiveness through
the input of the expert panel.
The process begins with the selection of a focused
question that can lead to action and the establishment
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tion. Ideally, and for the sake of efficiency, relevant pub-
lished and unpublished scientific evidence relating to
the question is gathered from an existing systematic
review. A list of potentially important outcomes is then
created which panel members must independently rate
according to importance ranging from unimportant to
critical. The improvement of outcomes with high patient
importance (i.e., considered critical) should lead to
stronger recommendations [23].
Following the rating of the importance of outcomes,
the quality of the evidence is then rated. A number of
factors can increase or decrease the quality rating and
this should reflect the confidence in the studies’ esti-
mates of benefits and harms.
Finally, the evidence, its quality rating and the out-
come information is synthesized succinctly and trans-
parently in evidence profiles. These profiles guide the
panel in deciding on the strength of recommendation
according to the tradeoffs between benefits and harms
of the various alternatives.
Based on conceptual arguments and past experience
with the process, many developers and users of GRADE
believe that this process can be applied across all forms
of intervention [24]. Others have argued that a single
system cannot adequately address evidence across a
wide range of contexts without being too complex to be
useful [25,26]. Until now, GRADE has been used pri-
marily to address topics in the field of medicine [e.g.,
[23,27,28]]. CYMH is an area in need of a more efficient
and effective approach to producing credible knowledge.
Furthermore, it is an area in which the potential of the
GRADE method has not been evaluated.
Current Study
Against this backdrop, the Provincial Centre of Excellence
for Child and Youth Mental Health at the Children’s
Hospital of Eastern Ontario completed a pilot project to
investigate the use of a streamlined version of the GRADE
approach. Autism intervention research was identified as a
suitable and interesting area in which to pilot test this
methodology. Specifically, this streamlined method was
used to determine current credible knowledge concerning
the effects of parent-implemented, early intervention for
children with autism. Implementing a methodology such
as GRADE has considerable implications for improving
efficiency, communication, and clinical decision-making.
GRADE may facilitate the progression of the CYMH field
toward greater use of evidence-based practice by service
providers. This pilot study is the first step in evaluating
the feasibility of this methodology as applied to CYMH
research and determining whether any modifications are
necessary in its application to this field. The findings
related to autism as well as the strengths and limitations
of the approach will be discussed.
Autism Research
The history of controversy surrounding autism makes this
area suitable for this pilot project and is certainly illustra-
tive of the importance of an established methodology for
determining credible knowledge in the field of CYMH.
Autism research has, for example, seen the persistence of
a dispute surrounding evidence concerning causal linkages
associated with the measles-mumps-rubella (MMR)
vaccine or the vaccine preservative thimerosal. Notwith-
standing, there has been no evidence to support an asso-
ciation between an MMR vaccine and autism, nor is there
a plausible biological mechanism [as reviewed by 29].
Valuable time and resources were used to conduct as
many as twenty studies to definitively respond to a study
[30], whose arguments had many flaws that need not be
explored here [29,31,32].
There has also been intense debate surrounding the
evidence base and suitability of the variety of educational
strategies and interventions that have been developed for
individuals with autism [33-37]. For instance, controversy
exists regarding the necessary intensity of intervention to
achieve positive outcomes, the use of certain outcomes
and the efficacy of one program compared to another
[38]. Some approaches have also been popular with par-
ents, but many professionals have not embraced them
enthusiastically, again leading to considerable contro-
v e r s y[ 3 9 ] .W h i l ed e b a t ei sc l e a r l yh e a l t h yi nf u r t h e r i n g
the scientific research in relation to these practices, the
level of uncertainty in this area has resulted in profes-
sionals, parents, and policy makers receiving confusing
and sometimes unreliable information about the relative
effectiveness of interventions [6].
Narrative reviews of interve n t i o n si nt h i sa r e ah a v e
sought to address this problem by identifying evidence-
based treatments. Unfortunately, many of these reviews
have not taken a systematic approach, limiting their com-
prehensiveness and validity [33,35,40-44]. Alternatively,
systematic reviews have included a wider range of evi-
dence but most have also been found to suffer from
methodological weaknesses that make them susceptible
to bias [45]. Other reports have taken a systematic
approach to the scientific evidence along with expert
clinical opinion and took many years to complete. For
instance, the National Autism Centre [46] recently com-
pleted a review of effective treatments for autism. This
review took four years and required substantial resources.
Still, others using this approach could not provide precise
recommendations regarding specific interventions.
The National Research Council [36] and New York
State Department of Health [47] each conducted a
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lines intended to identify effective practices. These
reports did not recommend specific interventions. The
reports cited a lack of well-controlled studies and an
inability to compare interventions between studies. This
was stated to be a result of varying descriptions of inter-
ventions, participants, treatment fidelity and other meth-
odological considerations. Instead, both reports
identified several key features of successful approaches
to the education of children with autism, including early
intervention after diagnosis, intensive instructional pro-
gramming, as well as parental involvement in educating
their child.
Parent-implemented interventions have been a parti-
cular focus in recent reviews, as increased parental skills
allow for continual opportunities for children’sl e a r n i n g
across a range of situations [48,49]. Even in using a
more narrowly defined scope of interventions for chil-
dren with autism, the authors of these reviews were
unable to provide recommendations as to specific inter-
ventions and offered few implications for practice. This
study aims to show that a modified GRADE approach
can improve on these attempts at developing recom-
mendations when applied to a CYMH topic.
Methods
The Grade Approach
The process used for this pilot project was adapted from
that described by the GRADE working group and is
more fully described elsewhere [19,24,50-53]. The
approach represents an explicit assessment of the quality
of evidence, the balance between benefits and risks and
the strength of recommendations. Separating the judg-
ments of the quality of the evidence and the strength of
recommendations is a critical and defining aspect of
GRADE.
Adjustments to the process were made throughout the
course of the pilot project to adapt the method in
answering a CYMH question. Any changes to the process
are noted. The question selected for this pilot project
was: What is the current credible knowledge concerning
the effects of parent-implemented, early intervention for
their children with autism?
A detailed literature search was performed for existing
systematic reviews that addressed this question. Unfor-
tunately, systematic reviews by Diggle, McConachie &
Randle [48] and McConachie & Diggle [49] related to
this question used eligibility criteria that may have been
too narrow. A limited number of heterogeneous studies
were identified that were not comparable, and did
not lead to specific and precise recommendations [54].
Specifically, the former excluded studies that used non-
random allocation of groups, while both studied chil-
dren aged only one to six years with any diagnosis on
the autism spectrum. Broader criteria could lead to
more informative recommendations by including non-
randomized studies and a wider age range, resulting in a
broader range of interventions reviewed. As a result,
eligibility criteria were specified independent of the sys-
tematic reviews, as follows:
(1) Families had to have at least one child who
received a formal diagnosis of autism.
(2) Parent-implemented: At least one parent was for-
mally trained to deliver an intervention for their
child with autism, which was different in some way
from any intervention(s) delivered by service
providers.
(3) Early intervention: At the time of study initiation,
within each study group at least one recipient of a
parent-implemented intervention had been under
eight years of age.
(4) Research designs: prospective and controlled.
(5) All publication dates considered.
(6) Effects: any outcomes (e.g., child, interaction,
parent, system-related), which includes benefits and
harms.
Based on these criteria, an independent information
specialist searched the following databases: ERIC, The
Cochrane Library, MEDLINE, EMBASE, PsycInfo,
CINAHL, and Dissertation Abstracts International.
Other sources of information were examined including
the bibliographies of systematic and narrative reviews
and reference lists of key articles identified through the
search strategy. Screening by three independent screeners
of the results yielded 11 primary studies to be included
[55-65]. This deviates from the original GRADE method
in that the evidence-base is typically independently estab-
lished by an existing systematic review in a GRADE
review. Given the issues with the existing systematic
reviews on this topic (noted above), the procedure was
modified in the current study to have an independent
information specialist search for individual studies. This
subsequently modifies the procedure for appraising the
evidence, as described below.
A panel, which included three clinical and methodolo-
gical experts in autism research, was then formed. In
this pilot project, one role of the panel was to serve as a
proxy for end users in determining the values and pre-
ferences of those end users in rating the importance of
outcomes. The inclusion of additional members was
beyond the resources of this work.
Outcome Ratings
In addition to using the panel’s experience, an extensive
literature search was performed to identify preference
estimates from population-based studies in order to gain
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importance of outcomes. These studies are intended to
provide information that reflects the values, beliefs and
preferences of those affected by autism. The panel could
use these studies in rating the importance of outcomes.
The panel then created a list of potentially important
outcomes to rate, independent of the primary studies.
Outcomes are rated on a scale from 1-9: a rating of 7-9
indicating that the outcome is critical for a decision or
recommendation; a rating of 4-6 indicating it is impor-
tant; and, a rating of 1-3 indicating it is not important.
Quality of Evidence
Quality of the evidence was then assessed using the
GRADE four-category system (high, moderate, low and
very low quality). The quality of the evidence reflects the
extent to which one can be confident that the estimates
of the benefits and harms of a researched intervention
are accurate. Evidence based on randomized controlled
trials begins with a high quality rating, observational stu-
dies with a low rating and any other evidence with a very
low rating. However, studies may then be upgraded or
downgraded. Five limitations–related to study quality,
consistency, directness, precision, and reporting bias–
may lead to downgrading. Upgrading the quality of the
evidence may result from large effects, dose-response
gradient and if all plausible confounding variables or
biases would decrease the demonstrated effect, such as
only sicker patients receiving an experimental interven-
tion, yet still faring better. It is important to note that evi-
dence that is downgraded for any reason cannot be
upgraded. To ensure transparency and objectivity, the
panel provided explicit reasons for downgrading and
upgrading by including footnotes in the evidence profiles;
this is a requirement of the GRADE system.
Due to the heterogeneity of the evidence base for the
present application, namely that each study evaluated a
different intervention using a different set of outcomes
along with variations in the specific populations studied
and those implementing the interventions, study results
could not be combined nor directly compared. This
diverged from the typical GRADE method where studies
evaluating the same outcomes are combined and the
quality of each outcome is then evaluated separately. In
the present modified version of GRADE, studies were
individually appraised for quality on a number of dimen-
sions (see Table 1). The labels high, moderate, low and
very low quality evidence were then applied to indivi-
dual studies as opposed to a synthesized body of evi-
dence, as in the original GRADE method. For each
intervention considered, the panel then formulated a
consensus recommendation based on the panel mem-
bers’ judgments regarding the balance between the ben-
efits, harms, and values and preferences (i.e., the
desirability or preference that individuals exhibit for a
particular outcome) of the intervention. Due to the lim-
ited resources of this pilot-project, information on costs
(i.e., resource utilization) were not acquired, and they
were not considered when making a recommendation.
Strength of Recommendations
The strength of recommendations was then determined
according to the tradeoffs between benefits and harms of
the various alternatives. The strength of a recommenda-
tion reflects the extent to which one can be confident
that the desirable effects of an intervention outweigh the
undesirable effects. Although the level of confidence is a
continuum, the GRADE system offers two levels of recom-
mendations for or against treatments (i.e., strong and
weak), according to the extent of difference between bene-
fits and harms. The strength of a recommendation is also
influenced by the values and preferences of end users, in
that critical outcomes are the primary factors for establish-
ing a recommendation. This allows the GRADE system to
emphasize that weak recommendations in the face of high
quality evidence and vice versa, can occur. This is because
other factors, beyond the quality of the evidence, including
the values and preferences of the relevant population and
the importance of the outcomes, impact the strength of a
recommendation [20]. Given that the heterogeneity of the
evidence did not allow for a synthesis of the evidence, the
labels strong and weak were applied to individual interven-
tions, as opposed to the body of the evidence as in the
original GRADE method.
Recommendations included details about the population
and intervention. This should aid in the interpretation of
the strength of the recommendations and help clinical
Table 1 Factors assessed in critically appraising the
evidence
Factors that might decrease
quality of evidence
Factors that might increase
quality of evidence
￿ Lack of allocation concealment
￿ Lack of blinding (particularly for
subjective outcomes)
￿ Failure to adhere to an intention
to treat analysis
￿ Stopping early for benefit
￿ Selective outcome reporting
￿ Poor matching of groups in
nonrandomized studies or
inappropriate comparison group
(e.g., children with more serious
behavioural problems placed in
control group)
￿ Absence of treatment fidelity
assessment
￿ Inadequate description of
intervention and those delivering
intervention
￿ Insufficient follow-up period or
lack of reporting on losses to
follow-up
￿ Large magnitude of effect
￿ Plausible confounding, which
would reduce a demonstrated
effect
￿ Dose-response gradient
(increased intensity of treatment
leads to enhanced benefits)
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some of the judgments leading to the recommendations
are subjective, the decisions made are explicit and trans-
parent in the remarks that go along with the recommen-
dations. Specific suggestions for new studies to be
undertaken were also noted (see example in Additional
file 1).
Results
It took approximately four months to complete this pilot
project. A clear answer to the original question as to which
parent-implemented intervention is the most effective, was
not reached due to the heterogeneity of the studies
included (see Table 2 for a description of the interven-
tions). The content of the interventions evaluated differed
in almost all studies, while different sets of outcome mea-
sures were also used. Any combination or meta-analysis of
the data was simply not possible. As a result, specific
recommendations were made fore a c hi n t e r v e n t i o ns t u -
died. These detailed recommendations included a sum-
mary of each piece of evidence with emphasis on the key
characteristics (e.g., age group studied, outcomes showing
improvement, etc.) influencing a recommendation identi-
fied by the panel (see example in Additional file 1).
Overall, the quality of the evidence ranged from high to
very low, based on seven randomized controlled trials and
four observational, or quasi-experimental, studies (see
Figure 1). The factors that led to downgrading the quality
of some studies included a lack of blinding, inappropriate
matching of control groups and/or lack of clarity in
describing the population, intervention and/or study
design. A “weak positive” recommendation was made for
each of the eight interventions compared to a no interven-
tion or local services control group. A “weak positive”
recommendation was also made for one intervention in
each of the four studies comparing interventions; one
study compared an intervention to both a group receiving
local services and a group receiving a different interven-
tion. All of the studies provided some evidence in favour
of the studied intervention, as each demonstrated some
positive effects and the remaining showing no significant
change. Notably, no study found evidence of any harmful
effects of the interventions (see Table 3 for a summary of
the evidence and recommendations). Given that costs
were not considered and each study demonstrated positive
effects and no harms, our results suggest that parent-
implemented interventions for children with autism are
likely to be beneficial. The exclusion of costs is very likely
to have had an effect on the strength of recommendations,
as studies were of varying quality, though evidence of ben-
efits on an outcome were required in order to recommend
an intervention. By completing this process, gaps and
weaknesses in this specific area of research were also
identified.
Discussion
This pilot project provided evidence of the potential uti-
lity and feasibility of the streamlined GRADE process in
Table 2 Descriptions of the studied interventions
Study Intervention Sample Size
Aldred et al. (2005) Therapist delivered, manual-based program for training and educating parents in
adapted communication.
Treatment = 14
Control = 14
Drew et al. (2003) Speech and language therapist delivered program aimed to train parents to
develop their child’s joint attention skills and joint action routines.
Treatment = 12
Control = 12
Howlin & Rutter (1987) A behavioural, linguistic and social training program used to teach parents
language modification techniques, management training and behavioural
procedures.
Treatment = 16
Control = 16
Koegel et al. (1996) Pivotal Response Training, a naturalistic paradigm emphasizing motivational
procedures and responsivity to multiple cues to improve parent-child interaction.
Treatment = 7
Control = 10
McConachie et al. (2005) “More Than Words” course aimed at improving parents’ understanding of autism
and facilitating communication.
Treatment = 26
Control = 25
Neef (1997) A pyramidal model of parent training by peers to instruct parents in making use
of skill training opportunities during daily routines.
Treatment = 14
Control = 12
Ozonoff & Cathcart (1998) Individualized TEACCH-based home program focusing on cognitive, academic,
and prevocational skills.
Treatment = 11
Control = 11
Rickards et al. (2000) Specialist pre-school teacher delivered, home-based program using discussion,
direct skills training and adaptation of the home environment to the child.
Treatment = 18
Control = 21
Schreibman et al. (1995) Pivotal Response Training, a naturalistic paradigm emphasizing motivational
procedures and responsivity to multiple cues to improve parent-child interaction.
Treatment = 10
Control = 7
Tonge et al. (2001) Special educator or psychologist delivered, manual-based, parent education and
behaviour management intervention.
Treatment = 35
Control = 35
Wang (2008) The author delivered a program aimed at improving the interactive skills of
parents using applied behaviour analysis and naturalistic teaching principles
Treatment = 14
Control = 11
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this method in this area, it provides a unique contribu-
tion, though modifications to the process were required
and certain limitations will have to be addressed in
future studies in order for the GRADE method to
achieve its potential in this field. A synthesis of the evi-
dence relating to parent-implemented interventions for
their child with autism was completed, along with an
objective evaluation of this evidence. Following the eva-
luation of the evidence, recommendations were devel-
oped in detail to facilitate interpretation by decision
makers for whom the recommendations are intended.
This reporting should ensure that decision makers have
all of the information required to judge the quality of a
recommendation, determine its applicability, and adapt
it, if necessary. Overall, it appeared that early, parent-
implemented interventions for autism result in positive
effects that outweigh any undesirable effects (though
publication bias was not assessed and could have
impacted the results of this study). However, as opposed
to an overall recommendation for these interventions as
aw h o l e ,s p e c i f i cr e c o m m e n d a t i o n sh a dt ob em a d e
based on the question of whether a particular interven-
tion’s benefits outweighed its harms, a necessary depar-
ture from the original GRADE method.
Limitations
The first limitation may also be considered one of the
strengths of this study. The GRADE approach was being
implemented in a new field of research. Yet, as a result,
there were no previous detailed applications or standards
to draw from in the literature and modifications to the
process were required. Some of the lessons learned from
the current application of GRADE should inform future
implementations of this approach in CYMH. This may
also suggest that another panel may not reproduce the
same results. In fact, others may disagree with aspects of
our application to GRADE in this area of research and
the subsequent grading of the quality of evidence and
strength of recommendations. However, the transparency
maintained by this process should allow others to under-
stand the decisions made by this panel. For example, stu-
dies may be downgraded due to a lack of precision when
there are very few patients or events, but there are no
defined standards for these terms. Consequently, this
panel followed the GRADE principle that a study may
require greater precision in support of a recommendation
when there is a close balance between the advantages
and disadvantages of an intervention [66]. Given the lack
of harmful events in the studied interventions, this was
not the case here. Furthermore, the current panel consis-
tently recommended the use of interventions for which
there was no evidence of harm and some demonstrated
benefit on one of the important outcomes. This is a par-
ticular judgment on the part of the current panel that
has impacted the recommendations. Taken together,
future iterations of this process may use panels with dif-
ferent values and judgments that would raise the thresh-
old for demonstrated benefit as well as decide on a
minimum sample size, which, if not met, would be down-
graded for a lack of precision. Regardless of these deci-
sions, they should continue to be made explicit and
applied consistently.
The lack of variability in the composition of the panel
may also be considered a limitation in the present appli-
cation of GRADE. This panel was composed of clinical
and methodological experts in the area of autism
research. This may have reduced the variability of opi-
nion in establishing the values and judgments and cre-
ated a conflict of interest in reviewing and appraising
evidence in their own field. This became a more promi-
nent factor when the panel was required to appraise
individual studies and provide individual recommenda-
tions for each intervention as part of the modified
GRADE approach. However, these experts also had
unique insight into the values and preferences of end-
users, for which they were used as a proxy, as well as
previous experience in this area of research that facili-
tated the timely completion of this pilot project. More-
over, these modifications to the process were necessary
due to the evidence base and, again, all decisions were
made transparent.
Examining the cause of the somewhat unsatisfactory
finding, it is seemingly a product of the evidence and not
due to any shortcomings in the GRADE method itself.
The results of the studies could not be combined or com-
pared due to the high degree of heterogeneity in the evi-
dence base. Two interventions were rarely comparable in
terms of the content of the intervention, outcomes mea-
sured, specific population studied or those implementing
the interventions. Therefore, it was not always possible to
construct a consistent account of the effects of an
Figure 1 Quality Ratings. Frequency count of the quality of the
evidence as rated by the panel.
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Page 7 of 12Table 3 Summary of the Evidence
Study Quality
Rating
Factors affecting quality
Strengths (+)/Weaknesses(-)
Recommendation* Best Estimates
Aldred et al.
(2005)
High + RCT
+ Independent randomization
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
Weak + Improved symptom severity, social communication
skills and parent perception of child’s communication
skills
Drew et al.
(2002)
Moderate + RCT
+ Appropriate randomization
+ Clear outcome reporting
+ Low risk of bias
+Valid outcome measures
- poorly matched groups (gender)
- lack of blinding
Weak + Improved Communication Skills
Howlin &
Rutter (1987)
Low + Appropriately matched control group
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
- Quasi-Experimental design
Weak + Improved mother/child speech and interaction
Koegel et al.
(1996)
High + RCT
+ Appropriate randomization
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
Weak + Improved parents’ global style of interaction with their
child
McConachie
et al. (2005)
Low + RCT
+ Appropriately matched control group
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
- Quasi-Experimental design
Weak + Improved children’s vocabulary and parents’ use of
facilitative strategies
Neef (1997) Very Low + Low risk of bias
- Quasi-Experimental design
- Inappropriately matched control group
- Allocation Concealment/blinding
- Incomplete outcome reporting
- Undetermined validity of outcome
measures
Weak + Improved parent teaching skills and child skills
development
Ozonoff &
Cathcart
(1998)
Very Low + Appropriately matched control group
+ Low risk of bias
+ Valid outcome measures
- Quasi-Experimental design
- lack of blinding
- Incomplete outcome reporting
Weak + Improved overall development, imitation, fine and
gross motor skills and nonverbal conceptual skills
Rickards
et al. (2000)
High + RCT
+ Appropriate randomization
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
Weak + Improved children’s IQ and behaviour problems
Schreibman
et al. (1995)
Moderate + RCT
+ Appropriate randomization
+ Allocation Concealment/blinding
+ Low risk of bias
+ Valid outcome measures
- Incomplete outcome reporting
Weak + Improved parental affect while interacting with their
child
Tonge et al.
(2001)
High + RCT
+ Independent randomization
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
Weak + Improved self-reported parent mental health
Michael Van Adel et al. BMC Health Services Research 2011, 11:60
http://www.biomedcentral.com/1472-6963/11/60
Page 8 of 12intervention. This is a common finding in mental health,
and specifically autism research [33,36,45,48,49,67,68].
Research in this area has been identified as containing
numerous gaps and being too heterogeneous to allow
for direct comparisons of interventions [36,68]. A num-
ber of directions need to be pursued in order to allow
for these comparisons. Specific areas to be pursued
include: studying a wider range of outcomes; lengthen-
ing the time to follow-up assessments; assessing mod-
erators and mediators of treatment outcomes; and,
testing varied approaches to treatment delivery or even
replicating past research [12,68,69]. An in-depth search
of studies addressing these factors in relation to autism
interventions was conducted for this pilot project and
returned few results [e.g., [70,71]]. Studies addressing
these factors would allow for mental healthcare provi-
ders and users to make the most informed decisions
possible for each individual. Furthermore, the use of
common, agreed upon outcome measures including
child, parent, family and interactions variables, would
facilitate the comparison of studies. Moreover, this
research would produce more valuable information by
using minimal standards in design and reporting on the
interventions and participants. To this end, guidelines
could be followed to improve the reporting of how stu-
dies were planned, conducted and analyzed [e.g.,
[72,73]].
The current approaches to synthesizing and evaluating
this evidence cannot overcome the limitations in the
research. An assumption of these approaches is that the
development of the evidence-base has considered the fit
between the intervention and its use in clinical practice.
In reality, this fit has rarely been taken into account.
Moreover, many make the assumption that all rando-
mized control trials are of a high quality since they are
generally considered the gold standard in research. The
difficulty with this assumption is that there are situations
where randomized control trials are impractical or
unethical [31,74]. This is particularly true in some areas
of CYMH research, where for a variety of logical reasons
these designs are infrequently applied, such as autism [6]
In effect, the evidence-base in CYMH is primarily
comprised of efficacy studies for which development is
based on theory, methods and models to evaluate treat-
ments that do not correspond to the demands of clinic
and community-based care [75]. As a result, clinical
research, and notably randomized controlled trials, does
not provide practitioners with definitive answers for
dealing with the individual-at-hand [76]. This may
account for the discrepancy between the scientific sup-
port of interventions and the lack of their use in these
settings [22,77-79].
Strengths
The GRADE approach explicitly addresses the fit
between the research and its use in practice through the
functions of the panel, a clear strength. While research
should still attend to the factors noted above, GRADE
can focus on the clinical relevance of the considerable
body of evidence already in existence. Another strength
of this approach is that it does not reduce the evidence
underlying an intervention to a simple Yes/No conclu-
sion, but it includes information about key variables
from the studies in the recommendations. This should
aid in the interpretation of the strength of the recom-
mendations and may affect clinical decision-making due
to diverse values and preferences of individuals imple-
menting the interventions. The short amount of time
required to prepare the recommendations was also a
strength of this process. It took four months to com-
plete the process, whereas guideline development and
systematic reviews can take up to two years or more
[4,9,10].
This approach also benefits from an explicit metho-
dology, transparency, consistency in judgments about
the quality of evidence, and linking evidence to recom-
mendations. Though evidence is linked to recommenda-
tions, the judgments about the quality of the evidence
and the balance of benefits and harms leading to the
recommendations are made separately. Not all grading
systems separate decisions regarding the quality of the
evidence from the strength of recommendations [19].
Those that fail to do so may create confusion. High
q u a l i t ye v i d e n c ed o e sn o tn e c e s s a r i l yi m p l ys t r o n g
recommendations, and strong recommendations can
arise from low quality evidence. GRADE also compels
the panel to consider all relevant outcomes and to
adhere to a consistent and comprehensive process in
evaluating the evidence. This is a key advantage of this
process, especially when considering that guideline
Table 3 Summary of the Evidence (Continued)
Wang (2008) High + RCT
+ Appropriate randomization
+ Allocation Concealment/blinding
+ Clear outcome reporting
+ Low risk of bias
+ Valid outcome measures
Weak + Improved the quality of parent’s interactions with their
child
*Recommendations are either Strong or Weak and For (+) or Against (-) the studied interventions; RCT = Randomized Controlled Trial.
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Page 9 of 12developers have been found to lack objectivity due to
excessive influence from industry and experts participat-
ing in the guideline panels, and to rarely abide by guide-
lines for the preparation of guidelines [8,80]
It should also be noted that GRADE has now been
adopted by a number of organizations including the
Cochrane Collaboration and the World Health Organiza-
tion [28,53]. The increased usage of this methodology and
presentation of its results, typically in summary of findings
tables, may result in more rapid, clear and consistent
translation of evidence. Furthermore, the results of one
implementation of GRADE could be used in subsequent
reviews quickly and transparently. For example, evidence
from a GRADE review of interventions for other disorders
on the autism spectrum could potentially be added to this
review, while being downgraded for a lack of directness.
These strengths contribute to our experience that
GRADE is a feasible approach in CYMH. Its methodol-
ogy promotes reconciliation between clinicians’, metho-
dologists’, administrators’ and patients’ perspectives
along with the scientific evidence. Eliminating this tradi-
tional separation, seen as a significant limitation in clini-
cal practice guidelines and systematic reviews, will help
the evolution of the CYMH field toward the use of
evidence-based practice by service providers.
Future Directions
Future implementations of the GRADE approach should
include a broader representation of stakeholders in the
panel than was used in this pilot project. Other mem-
bers of the panel could include those of varying levels of
service administration such as policy makers, parents,
and other practitioners. They would provide more varied
perspectives and reduce the gap between the evidence
and practice. For example, considering practical barriers
to implementation, such as funding restrictions or gaps
in clinical expertise could be especially helpful in mak-
ing the most useful recommendations. In addition,
including stakeholders of varying levels would help to
d r i v et h ek n o w l e d g ee x c h a n g eo ft h ef i n d i n g s .K n o w l -
edge exchange is an area in and of itself that should be
explored to provide guidance on the best procedure for
translating results in order to produce meaningful
change when using the GRADE method [81]. Other
considerations in future uses of GRADE include having
the details of the manualization of the intervention as
part of the evaluation of methodological quality. Man-
uals serve the important objective of making the recom-
mended treatments available for clinical training and
practice. The specification of sample characteristics in
the study could also be evaluated in the GRADE pro-
cess. These details reflect the recognition that specific
treatments may be efficacious only within a limited
range of individuals depending on such factors as their
age, sex, problem severity, socioeconomic status, and
ethnicity [82].
Conclusions
In conclusion, it was determined that it is feasible to
develop more timely recommendations in CYMH, speci-
fically early parent-implemented autism interventions,
using a modified version of the systematic and transpar-
ent GRADE approach. A definitive answer as to which
is the best intervention was not produced. However, the
GRADE approach appeared capable of providing a spe-
cific answer had the evidence been less heterogeneous
and directly comparable. Due to the heterogeneity of
the evidence a modified GRADE approach was presently
evaluated. As research in this area increases and fills in
the gaps identified above, it is important to have a
method to evaluate the benefits and risks of new inter-
ventions, in an efficient manner, as they arise. The
GRADE process meets this need and establishes credible
knowledge that leads directly to recommendations for
effective organization and delivery of CYMH care. Most
importantly, GRADE and the recommendations devel-
oped from it, will help CYMH service providers and
users to make treatment decisions that are informed by
the scientific and practice-based evidence.
Additional material
Additional file 1: Appendix - Sample Recommendation. Example of
recommendation from the pilot-project
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